Financial Performance - The company's operating revenue for Q1 2025 reached ¥3,156,902,838.56, representing a year-on-year increase of 10.96% compared to ¥2,845,099,846.77 in the same period last year[3] - Net profit attributable to shareholders was ¥184,741,510.38, up 10.53% from ¥167,134,125.97 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥171,298,757.04, reflecting a significant increase of 26.02% compared to the previous year's figure[3] - The basic and diluted earnings per share decreased by 5.60% to ¥0.1433 from ¥0.1518 in the same period last year[4] - Net profit for Q1 2025 was ¥213,729,247.30, compared to ¥175,657,298.21 in Q1 2024, representing a growth of 21.66%[24] - The total comprehensive income for the first quarter of 2025 reached CNY 215,307,461.12, an increase from CNY 176,679,722.88 in the same period of 2024, representing a growth of approximately 21.8%[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥30,565,032,169.54, an increase of 1.37% from ¥30,151,420,225.36 at the end of the previous year[4] - Total liabilities rose to ¥12,766,759,417.03 in 2025, up from ¥12,579,808,029.06 in 2024, indicating an increase of 1.49%[20] - The company's total assets increased to ¥30,565,032,169.54 in 2025 from ¥30,151,420,225.36 in 2024, marking a growth of 1.37%[20] - The total equity attributable to shareholders increased to ¥17,316,068,133.72 in 2025 from ¥17,118,862,583.15 in 2024, reflecting a growth of 1.15%[20] Cash Flow - The net cash flow from operating activities was negative at -¥139,794,495.08, compared to -¥346,041,501.57 in the previous year, indicating an improvement[3] - As of March 31, 2025, the company's cash and cash equivalents amounted to RMB 4.864 billion, down from RMB 5.457 billion at the end of 2024[17] - Cash inflow from operating activities totaled CNY 3,194,792,619.55 in Q1 2025, up from CNY 2,910,936,429.76 in Q1 2024, indicating a growth of about 9.8%[28] - The net cash flow from investing activities for Q1 2025 was -CNY 451,139,864.48, slightly improved from -CNY 545,776,178.57 in Q1 2024[29] - The total cash and cash equivalents at the end of Q1 2025 were CNY 4,667,706,512.92, compared to CNY 2,259,625,011.69 at the end of Q1 2024, showing a significant increase of approximately 106.5%[30] Operational Highlights - The high-end fluorine materials segment saw a gross profit increase of 42.9%, with a gross margin improvement of 3.1 percentage points[14] - The electronic gas business experienced a gross profit growth of 25.6%, with a gross margin increase of 1.4 percentage points[14] - The high-end manufacturing chemical materials segment's gross profit decreased by 18.6%, with a gross margin reduction of 8.7 percentage points[14] - Key projects are progressing as planned, including the completion of a 1,000-ton per year perfluoroolefin project and a 26,000-ton per year high-performance organic fluorine materials project[15] Shareholder Information - The company reported a total of 16,303 common shareholders at the end of the reporting period[10] Research and Development - The company has newly approved 2 national-level R&D platforms and received certification for its domestically produced aircraft tire[14] - Research and development expenses for Q1 2025 were ¥184,588,586.17, slightly down from ¥189,402,001.61 in Q1 2024, a decrease of 1.66%[23] Financial Adjustments - The financial data for the previous year was adjusted due to the merger with Zhonghua Lantian Group and Guilin Lanyu Aviation Tire Development Co., Ltd.[5]

Financial Performance - Haohua Technology achieved a net profit attributable to shareholders of 1,053,796,305.15 yuan for the fiscal year 2024[6]. - The company's operating revenue for 2024 was approximately CNY 13.97 billion, a decrease of 3.83% compared to CNY 14.52 billion in 2023[25]. - The net profit attributable to shareholders for 2024 was approximately CNY 1.05 billion, down 10.94% from CNY 1.18 billion in 2023[25]. - The basic earnings per share for 2024 was CNY 0.9531, reflecting a decrease of 10.71% compared to CNY 1.0674 in 2023[24]. - The weighted average return on equity for 2024 was 8.66%, a decrease of 1.20 percentage points from 9.86% in 2023[24]. - The net cash flow from operating activities for 2024 was approximately CNY 738.23 million, down 30.53% from CNY 1.06 billion in 2023[25]. - The total assets at the end of 2024 were approximately CNY 30.15 billion, an increase of 18.86% from CNY 25.37 billion at the end of 2023[25]. - The net assets attributable to shareholders at the end of 2024 were approximately CNY 17.12 billion, up 44.61% from CNY 11.84 billion at the end of 2023[25]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.86 yuan per 10 shares, totaling 368,949,639.63 yuan, based on a total share capital of 1,290,033,705 shares[6]. - The company will submit the profit distribution plan for shareholder approval at the 2024 annual general meeting[6]. - The total profit distribution for 2023 amounted to ¥315,369,937.22, representing approximately 35.05% of the net profit attributable to shareholders of the listed company for the year[188]. Corporate Governance and Compliance - Haohua Technology's board of directors and management have confirmed the accuracy and completeness of the financial report[5]. - The company has not reported any significant risks that could materially affect its operations during the reporting period[9]. - The company has no non-operating fund occupation by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[8]. - The audit report issued by Tianzhi International Accounting Firm confirms the financial report's standard unqualified opinion[5]. - The company held 4 shareholder meetings, 14 board meetings, and 10 supervisory meetings during the reporting period, demonstrating its commitment to corporate governance[186]. - The board has established four specialized committees to enhance decision-making and oversight, ensuring compliance with regulations and protecting shareholder interests[187]. Research and Development - The total R&D expenditure amounted to CNY 928,030,116.54, representing 6.64% of total revenue[8]. - The number of R&D personnel increased from 2,927 to 3,283, now comprising 28% of the total workforce[9]. - The company has maintained an average R&D investment intensity of around 7% over the past three years, positioning it at the forefront of the industry[75]. - The company has received over 400 significant technology awards, including more than 30 national technology invention and progress awards, showcasing its strong R&D capabilities[71]. - The company has established a multi-level R&D platform system with over 10 national-level research platforms and more than 40 provincial-level platforms, enhancing its innovation capabilities[72]. Market Expansion and Strategic Initiatives - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23]. - The company is focusing on enhancing its supply chain efficiency and compliance through training and monitoring, aiming for sustainable development in procurement practices[42]. - The company is actively expanding its industrial chain and enhancing its collaborative innovation capabilities across upstream and downstream sectors[80]. - The company is focusing on expanding its market presence and enhancing its financial services capabilities through strategic partnerships[195]. - The company is committed to improving operational efficiency and aims for over 50% of enterprises to reach "G4 leading level"[173]. Environmental and Safety Management - The company maintained a 100% compliance rate in occupational health checks and did not experience any major safety incidents during the reporting period[41]. - The company’s HSE management achieved the "four zeros" goal, indicating no major safety production accidents or environmental incidents[41]. - The company aims to achieve zero incidents of general and above production safety accidents, zero general and above environmental incidents, zero new occupational diseases, and zero major HSE negative public opinion as part of its HSE management goals[179]. Financial Position and Investments - Cash and cash equivalents increased by 76.01% to CNY 5,457,164,847.32 compared to the previous period[10]. - The company's equity capital increased by 41.53% year-over-year, attributed to the completion of a major asset restructuring and the issuance of new shares[104]. - The company raised 4.5 billion RMB through share issuance during the reporting period[85]. - The company completed the acquisition of 100% equity in Sinochem Blue Sky Group, significantly increasing its share in high-end fluorine materials and expanding product categories[5]. Future Outlook - The company anticipates a recovery and moderate growth in the chemical industry, driven by improved supply-demand dynamics and policy support[167]. - The company aims to achieve operating revenue of 16.103 billion yuan and a net profit of 1.276 billion yuan by 2025[170]. - The company is focusing on enhancing core functions and competitiveness through technology innovation and increasing R&D investment[170]. - The company is committed to increasing R&D investment to enhance its technological capabilities and achieve self-sufficiency in key chemical materials[183].

关于昊华化工科技集团股份有限公司 2024 年度涉及财务公司关联交易的存款、贷 款 等 金 融 业 务 的 专 项 说 明 天职业字[2025]17200-3 号 录 目 关于昊华化工科技集团股份有限公司 2024 年度涉及财务公司关联交易的存款、 贷款等金融业务的专项说明— 昊华化工科技集团股份有限公司 2024 年度涉及财务公司关联交易的存款、贷 款等金融业务情况汇总表- 您可使用手机"扫一扫"或近入"注册会计师行业统一流管平台（http://ac.co.cn.cn.cn.com.corv.cn）"进行查询。 【 】【 】【 】【 我进入"注册会计师行业统 ·准管平台（http://ac.con6.gov.cn） 我行查看 -1 -3 关于昊华化工科技集团股份有限公司 2024 年度涉及财务公司关联交易的存款、贷款等金融业务的专项说明 天职业字[2025]17200-3 号 昊华化工科技集团股份有限公司董事会: 我们接受委托,审计了昊华化工科技集团股份有限公司(以下简称"昊华科技")2024 年 12月 31 日的合并及母公司资产负债表、2024年度的合并及母公司利润表、合并及母公司 股东权益变动表、合并 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2025-038 昊华化工科技集团股份有限公司 关于使用募集资金置换预先已投入募投项目 及已支付发行费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 昊华化工科技集团股份有限公司（以下简称"公司"或"昊华科技"）于 2025 年 4 月 28 日召开第八届董事会第三十一次会议及第八届监事会第二十四次会议，审议通过 了《关于使用募集资金置换预先已投入募投项目及已支付发行费用的自筹资金的议案》， 同意公司使用募集资金置换预先已投入募投项目及已支付发行费用的自筹资金人民币 1,149,422,950.92 元，并调整募集资金投资项目金额。公司本次募集资金置换的时间距募 集资金到账时间未超过 6 个月。 一、募集资金基本情况 经中国证券监督管理委员会证监许可〔2024〕964 号文注册批复，公司向特定对象 发行人民币普通股（A 股）181,451,612 股，每股发行价格为人民币 24.80 元，募集资金 总额为人民币4,499,999,97 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2025－042 昊华化工科技集团股份有限公司 关于公司会计政策变更的公告 ●本次会计政策变更是昊华化工科技集团股份有限公司（以下简 称"公司"或"昊华科技"）根据中华人民共和国财政部（以下简称"财 政部"）发布的企业会计准则变更相应的会计政策。 ●本次会计政策变更无需提交公司董事会和股东大会审议。 ●本次会计政策变更不会对公司财务状况、经营成果产生重大影 响，不涉及以前年度的追溯调整，也不存在损害公司及股东利益的情 况。 一、会计政策变更概述 （一）会计政策的变更原因、变更内容和变更日期 2023 年 10 月 25 日，财政部发布《企业会计准则解释第 17 号》 （财会〔2023〕21 号），规定了"关于流动负债与非流动负债的划分"、 "关于供应商融资安排的披露"、"关于售后租回交易的会计处理"相关 内容，该解释规定自 2024 年 1 月 1 日起施行。2024 年 12 月 6 日， 财政部发布《企业会计准则解释第 18 号》（财会〔2024〕24 号），规 定对于不属于单项履约义务的保证类质量保证，应当按照《企业会计 准则第 13 号——或有 ...

中信证券股份有限公司 关于昊华化工科技集团股份有限公司 2024 年度募集资金存放与实际使用情况的专项核查报告 中信证券股份有限公司（以下简称"中信证券"或"独立财务顾问"）作为昊华化 工科技集团股份有限公司（以下简称"昊华科技"、"上市公司"或"公司"）的独立 财务顾问，根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》、《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关法律法规 和规范性文件的规定，对上市公司 2024 年度募集资金存放与实际使用情况进行了审慎 核查，具体情况如下： 一、募集资金基本情况 （一）募集资金金额及资金到位情况 经中国证券监督管理委员会证监许可〔2024〕964 号文注册批复，公司向特定对象 发行人民币普通股（A 股）181,451,612 股，每股发行价格为人民币 24.80 元，募集资金 总额为人民币4,499,999,977.60元，扣除不含增值税的发行费用人民币3,050,416.26元后， 募集资金净额为人民币 4,496,949,561.34 元。2024 年 12 月 25 日，独立财务顾问（牵头 主承销商）中信证券股份有限 ...

议》补充协议暨关联交易的公告 证券代码：600378 证券简称：昊华科技 公告编号：临 2025－034 昊华化工科技集团股份有限公司 关于与中化集团财务有限责任公司签署《金融服务协 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●交易简要内容：中化集团财务有限责任公司（以下简称"中化财 务公司"）为中国中化控股有限责任公司（以下简称"中国中化"）所 属非银行金融机构，为了持续优化财务管理、提高资金使用效率、降 低融资成本和融资风险，根据昊华化工科技集团股份有限公司（以下 简称"公司"）经营发展需要，公司拟与中化财务公司签署《金融服 务协议》之补充协议，对《金融服务协议》中部分条款进行调整。 ●本次交易构成关联交易 ●与该关联人累计已发生的各类关联交易情况：截至2025年4 月28日，公司在中化财务公司的存款余额为10.21亿元人民币及 566.81万元美元，存款余额折合人民币共计10.63亿元，并有11.33 亿元人民币的贷款余额，过去12个月实际使用授信发生额55.62亿 元。无追索权应收账款保理业务发生 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"）根据《上海 证券交易所上市公司自律监管指引第 3 号——行业信息披露》及附件 《第十三号——化工》要求，现将公司 2025 年一季度主要经营数据 披露如下： 说明：氟碳化学品外销量低于产量，主要为部分产品作为内部下游产品原料所致； 含氟精细化学品中有部分自用，导致产量高于销量；特种轮胎提前备货，导致产 量高于销量。 主要产品 2025年 1-3月产量 （吨） 2025年 1-3月销量 （吨） 2025 年 1-3 月销售 金额（万元） 氟碳化学品 28,782.15 22,448.10 96,026.90 含氟锂电材料 12,914.86 10,070.08 19,718.18 含氟聚合物 9,646.74 9,044.68 33,894.17 含氟精细化学品 12,264.40 4,848.77 21,396.11 含氟气体 2,491.35 2,413.65 23,289.13 橡胶制品（万件） 146.42 157.30 10 ...

关于对昊华化工科技集团股份有限公司 2024 年 度 非 经 营 性 资 金 占 用 及 其 他 关 联 资 金往来情况的专项说明 天 职 业 字 [2025]17200-2 号 目 录 关于对昊华化工科技集团股份有限公司 2024年度非经营性资金占 用及其他关联资金往来情况的专项说明 -- - 2024 年度非经营性资金占用及其他关联资金往来情况汇总表- -2 2024 年度非经营性资金占用及其他关联资金往来情况的专项说明 您可使用手机"扫一扫"或遗入"注册会计师行业统一流管平台（http://www.bl.gw.cn】"过行查验 "社"扫"或遗入"注册会计师行业统一流管平台（http://ac.org.gsv.cn）"过行查验 关于对昊华化工科技集团股份有限公司 天职业字[2025]17200-2 号 吴华化工科技集团股份有限公司董事会: 我们审计了昊华化工科技集团股份有限公司(以下简称"吴华科技")财务报表,包括 2024年12月31日的合并及母公司资产负债表、2024年度的合并及母公司利润表、合并及母公 司现金流量表、合并及母公司股东权益变动表以及财务报表附注,并于2025年4月28日签署了 标准无保 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2025-044 昊华化工科技集团股份有限公司 关于 2025 年一季度对外担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： （一）担保基本情况 统筹考虑浙江禾皓流动资金需求，浙化院与中国工商银行杭州市朝晖支行签 订《最高额保证合同》，由浙化院为浙江禾皓提供总额为 980 万元的连带责任保 证担保。 （二）本担保事项履行的内部决策程序 1．2024 年 8 月 29 日，公司第八届董事会第十九次会议审议通过《关于审议 调整公司 2024 年度为子公司及合营或联营公司融资提供担保计划的议案》，详 见公司于 2024 年 8 月 31 日披露的《昊华化工科技集团股份有限公司关于调整公 司 2024 年度为子公司及合营或联营公司融资提供担保计划的公告》（公告编号： 临 2024-059）。 2．2024 年 9 月 21 日，公司 2024 年第三次临时股东大会审议通过《关于审 议调整公司 2024 年度为子公司及合营或联营公司融资提供担保计划的 ...